458 related articles for article (PubMed ID: 26725097)
1. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
3. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
Gojo J; Lötsch D; Spiegl-Kreinecker S; Pajtler KW; Neumayer K; Korbel P; Araki A; Brandstetter A; Mohr T; Hovestadt V; Chavez L; Kirchhofer D; Ricken G; Stefanits H; Korshunov A; Pfister SM; Dieckmann K; Azizi AA; Czech T; Filipits M; Kool M; Peyrl A; Slavc I; Berger W; Haberler C
Neuro Oncol; 2017 Sep; 19(9):1183-1194. PubMed ID: 28371821
[TBL] [Abstract][Full Text] [Related]
5. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
Kilday JP; Mitra B; Domerg C; Ward J; Andreiuolo F; Osteso-Ibanez T; Mauguen A; Varlet P; Le Deley MC; Lowe J; Ellison DW; Gilbertson RJ; Coyle B; Grill J; Grundy RG
Clin Cancer Res; 2012 Apr; 18(7):2001-11. PubMed ID: 22338015
[TBL] [Abstract][Full Text] [Related]
6. Recurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.
Montgomery EY; Thirunavu V; Pagadala M; Shlobin NA; Plant-Fox AS; Lam S; DeCuypere M
J Neurosurg Pediatr; 2023 Feb; 31(2):132-142. PubMed ID: 36433871
[TBL] [Abstract][Full Text] [Related]
7. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
8. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
9. Utility of copy number variants in the classification of intracranial ependymoma.
Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
[TBL] [Abstract][Full Text] [Related]
10. Molecular predictive and prognostic factors in ependymoma.
Benson R; Mallick S; Julka PK; Rath GK
Neurol India; 2016; 64(2):279-86. PubMed ID: 26954807
[TBL] [Abstract][Full Text] [Related]
11. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
[TBL] [Abstract][Full Text] [Related]
12. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
13. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D
Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.
Amani V; Donson AM; Lummus SC; Prince EW; Griesinger AM; Witt DA; Hankinson TC; Handler MH; Dorris K; Vibhakar R; Foreman NK; Hoffman LM
J Neuropathol Exp Neurol; 2017 Jul; 76(7):595-604. PubMed ID: 28863455
[TBL] [Abstract][Full Text] [Related]
15. Isochromosome 1q as an early genetic event in a child with intracranial ependymoma characterized by molecular cytogenetics.
Granzow M; Popp S; Weber S; Schoell B; Holtgreve-Grez H; Senf L; Hager D; Boschert J; Scheurlen W; Jauch A
Cancer Genet Cytogenet; 2001 Oct; 130(1):79-83. PubMed ID: 11672779
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal imbalances in clear cell ependymomas.
Rickert CH; Korshunov A; Paulus W
Mod Pathol; 2006 Jul; 19(7):958-62. PubMed ID: 16648869
[TBL] [Abstract][Full Text] [Related]
17. Molecular staging of intracranial ependymoma in children and adults.
Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors.
Tihan T; Zhou T; Holmes E; Burger PC; Ozuysal S; Rushing EJ
Mod Pathol; 2008 Feb; 21(2):165-77. PubMed ID: 18084249
[TBL] [Abstract][Full Text] [Related]
19. Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.
Jünger ST; Andreiuolo F; Mynarek M; Dörner E; Zur Mühlen A; Rutkowski S; von Bueren AO; Pietsch T
Childs Nerv Syst; 2020 Nov; 36(11):2693-2700. PubMed ID: 32474813
[TBL] [Abstract][Full Text] [Related]
20. Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.
Pierce AM; Witt DA; Donson AM; Gilani A; Sanford B; Sill M; Van Court B; Oweida A; Prince EW; Steiner J; Danis E; Dorris K; Hankinson T; Handler MH; Jones KL; Karam SD; Serkova NJ; Vibhakar R; Foreman NK; Griesinger AM
Neuro Oncol; 2019 Dec; 21(12):1540-1551. PubMed ID: 31276586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]